https://www.nzdoctor.co.nz/everybody-patient-sheets

General Practice

Gordon Royle pradaxa
+Clinical

New Zealand contributes to trial success for dabigatran reversal

New Zealanders made up about a third of participants when idarucizumab was trialled internationally for reversing anti-coagulation

Read more
By Virginia McMillan
Friday 18 August 2017, 05:21 PM
0
Back to The newspaper

Article archive

Latest news

Yes, no and maybe: Pre-Budget likes, dislikes, hopes and heartstoppers

24/05/2019
1

It’s all in the genes

24/05/2019
0

Resthome service provider Third Age Health seeks second life with stock market listing

24/05/2019
0

Health trends leaving Government few ways to tighten screws on DHBs

24/05/2019
0

Genetic testing for common recessive disorders likely to be requested from GPs

24/05/2019
0

Bay of Plenty Māori health provider puts faith in rebuilt PHA to resist merger

23/05/2019
0

No rest for the dedicated – ex-Pharmac man Bryan Betty talks about what his future holds

23/05/2019
0

Concerns over ‘fragility’ of PRIME but partners not sitting on their hands

23/05/2019
0

Show us the money – where did Budget 2018’s billions get spent in health?

22/05/2019
0

St John considers using new funding to offset $2 million loss through industrial action

22/05/2019
0

Reading between the lines of the ministerial diaries

22/05/2019
1

Latest issue

Cover 22 May 2019

22 May 2019

View all issues

Facebook

New Zealand Doctor

Twitter